

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of skeletal muscle contraction (GO:0014819) | 6.06458920 |
| 2 | muscle filament sliding (GO:0030049) | 5.54923192 |
| 3 | actin-myosin filament sliding (GO:0033275) | 5.54923192 |
| 4 | response to peptidoglycan (GO:0032494) | 5.49346075 |
| 5 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 5.41582063 |
| 6 | sarcomere organization (GO:0045214) | 5.07543524 |
| 7 | desmosome organization (GO:0002934) | 4.94053743 |
| 8 | actin-mediated cell contraction (GO:0070252) | 4.70663811 |
| 9 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 4.65990752 |
| 10 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 4.41780181 |
| 11 | establishment of skin barrier (GO:0061436) | 4.39315433 |
| 12 | myofibril assembly (GO:0030239) | 4.28131156 |
| 13 | positive regulation by symbiont of host defense response (GO:0052509) | 4.26905228 |
| 14 | modulation by symbiont of host defense response (GO:0052031) | 4.26905228 |
| 15 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.26905228 |
| 16 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.26905228 |
| 17 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.26905228 |
| 18 | modulation by symbiont of host immune response (GO:0052553) | 4.26905228 |
| 19 | cardiac muscle hypertrophy (GO:0003300) | 4.23368361 |
| 20 | neutrophil activation involved in immune response (GO:0002283) | 4.21375653 |
| 21 | response to muramyl dipeptide (GO:0032495) | 4.20742194 |
| 22 | negative regulation of interleukin-12 production (GO:0032695) | 4.14908444 |
| 23 | regulation of water loss via skin (GO:0033561) | 4.12678517 |
| 24 | striated muscle hypertrophy (GO:0014897) | 4.08152426 |
| 25 | cardiac myofibril assembly (GO:0055003) | 4.05073922 |
| 26 | plasma membrane repair (GO:0001778) | 4.03298867 |
| 27 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.98332924 |
| 28 | actin filament-based movement (GO:0030048) | 3.96487990 |
| 29 | cellular extravasation (GO:0045123) | 3.84906780 |
| 30 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.81952387 |
| 31 | skeletal muscle contraction (GO:0003009) | 3.70464088 |
| 32 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.67184383 |
| 33 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 3.64267050 |
| 34 | skeletal muscle adaptation (GO:0043501) | 3.60077698 |
| 35 | cardiac muscle cell development (GO:0055013) | 3.59413096 |
| 36 | muscle hypertrophy (GO:0014896) | 3.59098747 |
| 37 | cardiac cell development (GO:0055006) | 3.55036540 |
| 38 | regulation of gamma-delta T cell activation (GO:0046643) | 3.48933674 |
| 39 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.48236915 |
| 40 | striated muscle adaptation (GO:0014888) | 3.48058203 |
| 41 | germinal center formation (GO:0002467) | 3.47678341 |
| 42 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.45455895 |
| 43 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.42822592 |
| 44 | cardiac muscle adaptation (GO:0014887) | 3.42666654 |
| 45 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.42666654 |
| 46 | muscle hypertrophy in response to stress (GO:0003299) | 3.42666654 |
| 47 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.41409007 |
| 48 | macrophage activation (GO:0042116) | 3.39827278 |
| 49 | detection of other organism (GO:0098543) | 3.39405041 |
| 50 | positive regulation of chemokine secretion (GO:0090197) | 3.36093589 |
| 51 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.35080914 |
| 52 | immunoglobulin mediated immune response (GO:0016064) | 3.34780331 |
| 53 | striated muscle contraction (GO:0006941) | 3.32712175 |
| 54 | skeletal muscle fiber development (GO:0048741) | 3.30708917 |
| 55 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.30566429 |
| 56 | detection of molecule of bacterial origin (GO:0032490) | 3.30396063 |
| 57 | regulation of interferon-alpha production (GO:0032647) | 3.29389793 |
| 58 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.27872293 |
| 59 | regulation of germinal center formation (GO:0002634) | 3.27002720 |
| 60 | hepatocyte apoptotic process (GO:0097284) | 3.23914451 |
| 61 | positive regulation of cardiac muscle cell differentiation (GO:2000727) | 3.23891974 |
| 62 | granulocyte activation (GO:0036230) | 3.22806570 |
| 63 | positive regulation of interferon-alpha production (GO:0032727) | 3.22105843 |
| 64 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.21789256 |
| 65 | actomyosin structure organization (GO:0031032) | 3.20506186 |
| 66 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.20300355 |
| 67 | ventricular cardiac muscle cell action potential (GO:0086005) | 3.18523021 |
| 68 | germ cell migration (GO:0008354) | 3.18004088 |
| 69 | skeletal muscle tissue regeneration (GO:0043403) | 3.15872901 |
| 70 | striated muscle atrophy (GO:0014891) | 3.15727522 |
| 71 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.14564141 |
| 72 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.14166076 |
| 73 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.12060804 |
| 74 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.11367182 |
| 75 | regulation of chemokine secretion (GO:0090196) | 3.09281740 |
| 76 | myeloid cell activation involved in immune response (GO:0002275) | 3.08477738 |
| 77 | myotube cell development (GO:0014904) | 3.06922728 |
| 78 | neutrophil mediated immunity (GO:0002446) | 3.05214353 |
| 79 | neutrophil activation (GO:0042119) | 3.02892467 |
| 80 | detection of bacterium (GO:0016045) | 3.02429258 |
| 81 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.01007860 |
| 82 | leukocyte aggregation (GO:0070486) | 3.00577920 |
| 83 | keratinization (GO:0031424) | 2.99069359 |
| 84 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.98217690 |
| 85 | cardiac muscle tissue morphogenesis (GO:0055008) | 2.98055227 |
| 86 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.97931478 |
| 87 | chemical homeostasis within a tissue (GO:0048875) | 2.97644693 |
| 88 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.97607250 |
| 89 | T-helper 1 type immune response (GO:0042088) | 2.95768077 |
| 90 | regulation of cell communication by electrical coupling (GO:0010649) | 2.92791720 |
| 91 | regulation of alkaline phosphatase activity (GO:0010692) | 2.92778120 |
| 92 | cardiac muscle contraction (GO:0060048) | 2.92695381 |
| 93 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.92616246 |
| 94 | detection of biotic stimulus (GO:0009595) | 2.91769523 |
| 95 | negative regulation of T cell mediated immunity (GO:0002710) | 2.90920111 |
| 96 | negative regulation of stress fiber assembly (GO:0051497) | 2.90554743 |
| 97 | detection of external biotic stimulus (GO:0098581) | 2.90342087 |
| 98 | negative regulation of inclusion body assembly (GO:0090084) | 2.89039698 |
| 99 | positive thymic T cell selection (GO:0045059) | 2.88773806 |
| 100 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.86698361 |
| 101 | muscle fiber development (GO:0048747) | 2.86259593 |
| 102 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.85670926 |
| 103 | muscle adaptation (GO:0043500) | 2.84859185 |
| 104 | defense response to protozoan (GO:0042832) | 2.84145253 |
| 105 | regulation of striated muscle contraction (GO:0006942) | 2.83583347 |
| 106 | striated muscle cell development (GO:0055002) | 2.83137407 |
| 107 | neutrophil chemotaxis (GO:0030593) | 2.82789636 |
| 108 | negative regulation of skeletal muscle tissue development (GO:0048642) | 2.82496809 |
| 109 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.82048150 |
| 110 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.82048150 |
| 111 | monocyte differentiation (GO:0030224) | 2.81766993 |
| 112 | cardiac right ventricle morphogenesis (GO:0003215) | 2.81073611 |
| 113 | myeloid leukocyte mediated immunity (GO:0002444) | 2.80885231 |
| 114 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.79925456 |
| 115 | negative regulation of cell killing (GO:0031342) | 2.79925456 |
| 116 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.79179874 |
| 117 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.78947493 |
| 118 | T-helper cell differentiation (GO:0042093) | 2.78947493 |
| 119 | muscle cell cellular homeostasis (GO:0046716) | 2.77812401 |
| 120 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.77267762 |
| 121 | protein localization to endosome (GO:0036010) | 2.77188199 |
| 122 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.77144072 |
| 123 | muscle tissue morphogenesis (GO:0060415) | 2.76577444 |
| 124 | neutrophil migration (GO:1990266) | 2.75561573 |
| 125 | regulation of sarcomere organization (GO:0060297) | 2.75160532 |
| 126 | microglial cell activation (GO:0001774) | 2.74207891 |
| 127 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.72709174 |
| 128 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.72084238 |
| 129 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.71995973 |
| 130 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.71448726 |
| 131 | establishment of endothelial barrier (GO:0061028) | 2.69662309 |
| 132 | positive regulation of interleukin-2 production (GO:0032743) | 2.69446532 |
| 133 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.69285768 |
| 134 | response to protozoan (GO:0001562) | 2.69259925 |
| 135 | regulation of relaxation of muscle (GO:1901077) | 2.69041474 |
| 136 | response to host immune response (GO:0052572) | 2.69036300 |
| 137 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.69036300 |
| 138 | response to inactivity (GO:0014854) | 2.68023103 |
| 139 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.67410471 |
| 140 | positive regulation of type 2 immune response (GO:0002830) | 2.67287035 |
| 141 | keratinocyte differentiation (GO:0030216) | 2.66730689 |
| 142 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.65805154 |
| 143 | regulation of chemokine biosynthetic process (GO:0045073) | 2.64973022 |
| 144 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.64596974 |
| 145 | cellular response to arsenic-containing substance (GO:0071243) | 2.64459981 |
| 146 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.62781421 |
| 147 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.62605235 |
| 148 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.62440593 |
| 149 | heart trabecula formation (GO:0060347) | 2.62099795 |
| 150 | regulation of mast cell degranulation (GO:0043304) | 2.62013330 |
| 151 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.61940736 |
| 152 | pathway-restricted SMAD protein phosphorylation (GO:0060389) | 2.61260595 |
| 153 | positive regulation of interferon-beta production (GO:0032728) | 2.60534429 |
| 154 | negative regulation of interleukin-6 production (GO:0032715) | 2.60472035 |
| 155 | positive regulation of mast cell activation (GO:0033005) | 2.60132095 |
| 156 | positive regulation of B cell differentiation (GO:0045579) | 2.58504418 |
| 157 | positive regulation of interleukin-6 production (GO:0032755) | 2.57703526 |
| 158 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.57528387 |
| 159 | coronary vasculature morphogenesis (GO:0060977) | 2.57487186 |
| 160 | tolerance induction (GO:0002507) | 2.57219212 |
| 161 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.56915009 |
| 162 | cytidine metabolic process (GO:0046087) | 2.56903856 |
| 163 | cytidine catabolic process (GO:0006216) | 2.56903856 |
| 164 | cytidine deamination (GO:0009972) | 2.56903856 |
| 165 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.56889634 |
| 166 | regulation of interleukin-12 production (GO:0032655) | 2.56137993 |
| 167 | fibroblast migration (GO:0010761) | 2.55929670 |
| 168 | regulation of T-helper cell differentiation (GO:0045622) | 2.55175243 |
| 169 | positive regulation of heat generation (GO:0031652) | 2.54154901 |
| 170 | regulation of interleukin-6 production (GO:0032675) | 2.53982393 |
| 171 | muscle contraction (GO:0006936) | 2.53942397 |
| 172 | negative regulation of interleukin-8 production (GO:0032717) | 2.53760603 |
| 173 | regulation of type 2 immune response (GO:0002828) | 2.53209302 |
| 174 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.52314332 |
| 175 | response to host defenses (GO:0052200) | 2.52314332 |
| 176 | negative regulation of systemic arterial blood pressure (GO:0003085) | 2.52246178 |
| 177 | surfactant homeostasis (GO:0043129) | 2.51686058 |
| 178 | positive regulation of myoblast differentiation (GO:0045663) | 2.50963133 |
| 179 | hemidesmosome assembly (GO:0031581) | 2.50883498 |
| 180 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.49110377 |
| 181 | muscle cell development (GO:0055001) | 2.48909145 |
| 182 | multicellular organismal water homeostasis (GO:0050891) | 2.47788397 |
| 183 | muscle system process (GO:0003012) | 2.47722962 |
| 184 | macrophage activation involved in immune response (GO:0002281) | 2.46803714 |
| 185 | cardiac muscle cell action potential (GO:0086001) | 2.46288821 |
| 186 | cell-substrate junction assembly (GO:0007044) | 2.45427629 |
| 187 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.44926205 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 5.26797172 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.11128407 |
| 3 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.59130367 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.32194655 |
| 5 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.02706676 |
| 6 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.01342649 |
| 7 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.66394392 |
| 8 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.45079426 |
| 9 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.24673304 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.14541908 |
| 11 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.12151924 |
| 12 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.10472034 |
| 13 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.07665421 |
| 14 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.05211967 |
| 15 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.02178161 |
| 16 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.99702570 |
| 17 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.98732705 |
| 18 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.96269637 |
| 19 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.93465169 |
| 20 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.90812368 |
| 21 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.90790298 |
| 22 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.86111884 |
| 23 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.84805698 |
| 24 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.83147326 |
| 25 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.82966343 |
| 26 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.82693784 |
| 27 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.81530436 |
| 28 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.80122813 |
| 29 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.79349490 |
| 30 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.74994096 |
| 31 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.71215467 |
| 32 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.70825468 |
| 33 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.69052106 |
| 34 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.68469051 |
| 35 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.68469051 |
| 36 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.67557547 |
| 37 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.63721832 |
| 38 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.63450596 |
| 39 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.62167545 |
| 40 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.58994302 |
| 41 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.58773488 |
| 42 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.58318307 |
| 43 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.54903025 |
| 44 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.53971479 |
| 45 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.53608658 |
| 46 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.53566880 |
| 47 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.53123612 |
| 48 | CJUN_26792858_Chip-Seq_BT549_Human | 1.50571541 |
| 49 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.50528484 |
| 50 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.50469243 |
| 51 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.47255599 |
| 52 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.47255599 |
| 53 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.45480489 |
| 54 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.44307174 |
| 55 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.43884110 |
| 56 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.43065300 |
| 57 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.41538308 |
| 58 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.41187645 |
| 59 | * MAF_26560356_Chip-Seq_TH1_Human | 1.38881113 |
| 60 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.37465609 |
| 61 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35788555 |
| 62 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.35563607 |
| 63 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.35434217 |
| 64 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.32706271 |
| 65 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.32706271 |
| 66 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.32706271 |
| 67 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.31401146 |
| 68 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.29255533 |
| 69 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.28877498 |
| 70 | RXR_22108803_ChIP-Seq_LS180_Human | 1.26818828 |
| 71 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.25865070 |
| 72 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.24870843 |
| 73 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.24209078 |
| 74 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.23938063 |
| 75 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.23101099 |
| 76 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.22325019 |
| 77 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.22324323 |
| 78 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.21015999 |
| 79 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.20375099 |
| 80 | TP53_16413492_ChIP-PET_HCT116_Human | 1.20275998 |
| 81 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.20107727 |
| 82 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.19965292 |
| 83 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.18812751 |
| 84 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.17767541 |
| 85 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.16863888 |
| 86 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.16548389 |
| 87 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.16509140 |
| 88 | MYC_22102868_ChIP-Seq_BL_Human | 1.16380669 |
| 89 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.16030453 |
| 90 | GATA1_22025678_ChIP-Seq_K562_Human | 1.15369032 |
| 91 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.14630075 |
| 92 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.13954644 |
| 93 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.12104510 |
| 94 | GATA2_19941826_ChIP-Seq_K562_Human | 1.11413998 |
| 95 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.11159570 |
| 96 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.10510209 |
| 97 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.09933972 |
| 98 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.09623170 |
| 99 | GATA1_19941826_ChIP-Seq_K562_Human | 1.09243488 |
| 100 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08968159 |
| 101 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.07737654 |
| 102 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.07186070 |
| 103 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.06100309 |
| 104 | MYB_26560356_Chip-Seq_TH1_Human | 1.05536457 |
| 105 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05462194 |
| 106 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.04183936 |
| 107 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.02494756 |
| 108 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.02483032 |
| 109 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.98327910 |
| 110 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.97368983 |
| 111 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.97004531 |
| 112 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.96555634 |
| 113 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.96344277 |
| 114 | KDM2B_26808549_Chip-Seq_K562_Human | 0.96069363 |
| 115 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 0.95774914 |
| 116 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.95551717 |
| 117 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95507179 |
| 118 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.95373035 |
| 119 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.95245344 |
| 120 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.93374664 |
| 121 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.93164407 |
| 122 | SPI1_23127762_ChIP-Seq_K562_Human | 0.92892393 |
| 123 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.91752115 |
| 124 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.91603584 |
| 125 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.91420317 |
| 126 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.91397246 |
| 127 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.91089148 |
| 128 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.90781830 |
| 129 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.90428170 |
| 130 | UTX_26944678_Chip-Seq_JUKART_Human | 0.90287348 |
| 131 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.90005991 |
| 132 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.89560793 |
| 133 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.89473561 |
| 134 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.88293069 |
| 135 | GATA3_26560356_Chip-Seq_TH2_Human | 0.87625890 |
| 136 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.86891083 |
| 137 | * MYB_26560356_Chip-Seq_TH2_Human | 0.86858480 |
| 138 | * SMRT_27268052_Chip-Seq_Bcells_Human | 0.86667296 |
| 139 | MAF_26560356_Chip-Seq_TH2_Human | 0.83728870 |
| 140 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81502690 |
| 141 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.80264636 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003941_abnormal_skin_development | 3.70838321 |
| 2 | MP0002796_impaired_skin_barrier | 3.31127162 |
| 3 | MP0003724_increased_susceptibility_to | 3.29523419 |
| 4 | MP0000751_myopathy | 3.21622733 |
| 5 | MP0003191_abnormal_cellular_cholesterol | 3.19679875 |
| 6 | MP0004510_myositis | 3.12558411 |
| 7 | MP0001835_abnormal_antigen_presentation | 3.05350045 |
| 8 | MP0000749_muscle_degeneration | 2.96437103 |
| 9 | MP0004145_abnormal_muscle_electrophysio | 2.95500816 |
| 10 | MP0002148_abnormal_hypersensitivity_rea | 2.94018829 |
| 11 | MP0003646_muscle_fatigue | 2.75932277 |
| 12 | MP0009785_altered_susceptibility_to | 2.75231356 |
| 13 | MP0003828_pulmonary_edema | 2.75004259 |
| 14 | MP0009278_abnormal_bone_marrow | 2.67013330 |
| 15 | MP0002419_abnormal_innate_immunity | 2.63201470 |
| 16 | MP0000750_abnormal_muscle_regeneration | 2.56950100 |
| 17 | MP0005000_abnormal_immune_tolerance | 2.53895970 |
| 18 | MP0004087_abnormal_muscle_fiber | 2.38610668 |
| 19 | MP0005025_abnormal_response_to | 2.31849093 |
| 20 | MP0005330_cardiomyopathy | 2.25112046 |
| 21 | MP0005451_abnormal_body_composition | 2.23424473 |
| 22 | MP0004484_altered_response_of | 2.21710620 |
| 23 | MP0004084_abnormal_cardiac_muscle | 2.21011299 |
| 24 | MP0002106_abnormal_muscle_physiology | 2.18679040 |
| 25 | MP0002723_abnormal_immune_serum | 2.16616468 |
| 26 | MP0004215_abnormal_myocardial_fiber | 2.08585715 |
| 27 | MP0003566_abnormal_cell_adhesion | 2.07497782 |
| 28 | MP0010234_abnormal_vibrissa_follicle | 2.05710846 |
| 29 | MP0000747_muscle_weakness | 2.01804368 |
| 30 | MP0010630_abnormal_cardiac_muscle | 1.94326739 |
| 31 | MP0002837_dystrophic_cardiac_calcinosis | 1.94289876 |
| 32 | MP0002269_muscular_atrophy | 1.93876711 |
| 33 | MP0004036_abnormal_muscle_relaxation | 1.92141337 |
| 34 | MP0002420_abnormal_adaptive_immunity | 1.88855183 |
| 35 | MP0005620_abnormal_muscle_contractility | 1.88849120 |
| 36 | MP0004947_skin_inflammation | 1.87618868 |
| 37 | MP0005058_abnormal_lysosome_morphology | 1.87410308 |
| 38 | MP0004185_abnormal_adipocyte_glucose | 1.86990843 |
| 39 | MP0001819_abnormal_immune_cell | 1.85878985 |
| 40 | MP0005275_abnormal_skin_tensile | 1.84645718 |
| 41 | MP0005670_abnormal_white_adipose | 1.84212768 |
| 42 | MP0009764_decreased_sensitivity_to | 1.82671390 |
| 43 | MP0003453_abnormal_keratinocyte_physiol | 1.81815218 |
| 44 | MP0002972_abnormal_cardiac_muscle | 1.78744346 |
| 45 | MP0005501_abnormal_skin_physiology | 1.78737316 |
| 46 | MP0001533_abnormal_skeleton_physiology | 1.76694624 |
| 47 | MP0003950_abnormal_plasma_membrane | 1.75959730 |
| 48 | MP0003045_fibrosis | 1.75546758 |
| 49 | MP0004130_abnormal_muscle_cell | 1.73154374 |
| 50 | MP0002998_abnormal_bone_remodeling | 1.68694883 |
| 51 | MP0005166_decreased_susceptibility_to | 1.68474578 |
| 52 | MP0003075_altered_response_to | 1.67113159 |
| 53 | MP0005369_muscle_phenotype | 1.63796666 |
| 54 | MP0003172_abnormal_lysosome_physiology | 1.63742330 |
| 55 | MP0009840_abnormal_foam_cell | 1.63295645 |
| 56 | MP0000759_abnormal_skeletal_muscle | 1.58787639 |
| 57 | MP0002405_respiratory_system_inflammati | 1.58407767 |
| 58 | MP0008004_abnormal_stomach_pH | 1.56491434 |
| 59 | MP0002254_reproductive_system_inflammat | 1.56412599 |
| 60 | MP0010155_abnormal_intestine_physiology | 1.54986050 |
| 61 | MP0002006_tumorigenesis | 1.54886125 |
| 62 | MP0001845_abnormal_inflammatory_respons | 1.54628731 |
| 63 | MP0002877_abnormal_melanocyte_morpholog | 1.52973773 |
| 64 | MP0003303_peritoneal_inflammation | 1.52898217 |
| 65 | MP0001544_abnormal_cardiovascular_syste | 1.48379627 |
| 66 | MP0005385_cardiovascular_system_phenoty | 1.48379627 |
| 67 | MP0001216_abnormal_epidermal_layer | 1.47440391 |
| 68 | MP0005666_abnormal_adipose_tissue | 1.42472474 |
| 69 | MP0000733_abnormal_muscle_development | 1.41948966 |
| 70 | MP0003656_abnormal_erythrocyte_physiolo | 1.40913305 |
| 71 | MP0004883_abnormal_blood_vessel | 1.38676768 |
| 72 | MP0003705_abnormal_hypodermis_morpholog | 1.37999535 |
| 73 | MP0009333_abnormal_splenocyte_physiolog | 1.34504615 |
| 74 | MP0000716_abnormal_immune_system | 1.32945433 |
| 75 | MP0008469_abnormal_protein_level | 1.32105161 |
| 76 | MP0002060_abnormal_skin_morphology | 1.29354748 |
| 77 | MP0005164_abnormal_response_to | 1.28028773 |
| 78 | MP0003690_abnormal_glial_cell | 1.26248537 |
| 79 | MP0002332_abnormal_exercise_endurance | 1.25562945 |
| 80 | MP0005167_abnormal_blood-brain_barrier | 1.24100399 |
| 81 | MP0002398_abnormal_bone_marrow | 1.23856320 |
| 82 | MP0005023_abnormal_wound_healing | 1.23521548 |
| 83 | MP0004381_abnormal_hair_follicle | 1.22602264 |
| 84 | MP0003195_calcinosis | 1.22475496 |
| 85 | MP0005076_abnormal_cell_differentiation | 1.21182692 |
| 86 | MP0000767_abnormal_smooth_muscle | 1.19395318 |
| 87 | MP0004808_abnormal_hematopoietic_stem | 1.17395570 |
| 88 | MP0001851_eye_inflammation | 1.15660593 |
| 89 | MP0002127_abnormal_cardiovascular_syste | 1.14877455 |
| 90 | MP0002138_abnormal_hepatobiliary_system | 1.13691277 |
| 91 | MP0000343_altered_response_to | 1.11633346 |
| 92 | MP0003221_abnormal_cardiomyocyte_apopto | 1.10834042 |
| 93 | MP0005310_abnormal_salivary_gland | 1.08612867 |
| 94 | MP0006138_congestive_heart_failure | 1.07604637 |
| 95 | MP0003137_abnormal_impulse_conducting | 1.05434115 |
| 96 | MP0000689_abnormal_spleen_morphology | 1.04819942 |
| 97 | MP0000858_altered_metastatic_potential | 1.04608615 |
| 98 | MP0003448_altered_tumor_morphology | 1.04584947 |
| 99 | MP0001800_abnormal_humoral_immune | 1.03500282 |
| 100 | MP0005397_hematopoietic_system_phenotyp | 1.03384754 |
| 101 | MP0001545_abnormal_hematopoietic_system | 1.03384754 |
| 102 | MP0000465_gastrointestinal_hemorrhage | 1.02661315 |
| 103 | MP0006082_CNS_inflammation | 1.02619115 |
| 104 | MP0003300_gastrointestinal_ulcer | 1.02188432 |
| 105 | MP0009384_cardiac_valve_regurgitation | 0.99686713 |
| 106 | MP0008260_abnormal_autophagy | 0.98832032 |
| 107 | MP0005387_immune_system_phenotype | 0.98758220 |
| 108 | MP0001790_abnormal_immune_system | 0.98758220 |
| 109 | MP0002971_abnormal_brown_adipose | 0.98743187 |
| 110 | MP0002277_abnormal_respiratory_mucosa | 0.97703646 |
| 111 | MP0003091_abnormal_cell_migration | 0.97320587 |
| 112 | MP0003279_aneurysm | 0.97198742 |
| 113 | MP0000604_amyloidosis | 0.96896881 |
| 114 | MP0002722_abnormal_immune_system | 0.96549168 |
| 115 | MP0002429_abnormal_blood_cell | 0.94644615 |
| 116 | MP0010678_abnormal_skin_adnexa | 0.92727428 |
| 117 | MP0000249_abnormal_blood_vessel | 0.91505091 |
| 118 | MP0001191_abnormal_skin_condition | 0.90776780 |
| 119 | MP0008961_abnormal_basal_metabolism | 0.90601718 |
| 120 | MP0002452_abnormal_antigen_presenting | 0.90438052 |
| 121 | MP0000377_abnormal_hair_follicle | 0.90108003 |
| 122 | MP0000383_abnormal_hair_follicle | 0.89674778 |
| 123 | MP0009931_abnormal_skin_appearance | 0.89447139 |
| 124 | MP0010771_integument_phenotype | 0.89100586 |
| 125 | MP0002132_abnormal_respiratory_system | 0.88529187 |
| 126 | MP0002933_joint_inflammation | 0.88394543 |
| 127 | MP0001853_heart_inflammation | 0.87318512 |
| 128 | MP0003567_abnormal_fetal_cardiomyocyte | 0.87136031 |
| 129 | MP0010352_gastrointestinal_tract_polyps | 0.85821846 |
| 130 | MP0010368_abnormal_lymphatic_system | 0.85085245 |
| 131 | MP0000266_abnormal_heart_morphology | 0.84380511 |
| 132 | MP0005623_abnormal_meninges_morphology | 0.83051356 |
| 133 | MP0005390_skeleton_phenotype | 0.82827529 |
| 134 | MP0002009_preneoplasia | 0.82812925 |
| 135 | MP0003436_decreased_susceptibility_to | 0.82179649 |
| 136 | MP0001784_abnormal_fluid_regulation | 0.80054204 |
| 137 | MP0005165_increased_susceptibility_to | 0.79843172 |
| 138 | MP0005671_abnormal_response_to | 0.78457409 |
| 139 | MP0009763_increased_sensitivity_to | 0.77357778 |
| 140 | MP0005464_abnormal_platelet_physiology | 0.76787000 |
| 141 | MP0000685_abnormal_immune_system | 0.76381473 |
| 142 | MP0005375_adipose_tissue_phenotype | 0.76192819 |
| 143 | MP0003763_abnormal_thymus_physiology | 0.75966144 |
| 144 | MP0001879_abnormal_lymphatic_vessel | 0.75926856 |
| 145 | MP0002166_altered_tumor_susceptibility | 0.75886705 |
| 146 | MP0002925_abnormal_cardiovascular_devel | 0.75772851 |
| 147 | MP0006054_spinal_hemorrhage | 0.75767789 |
| 148 | MP0002168_other_aberrant_phenotype | 0.75719127 |
| 149 | MP0002098_abnormal_vibrissa_morphology | 0.75361534 |
| 150 | MP0002128_abnormal_blood_circulation | 0.75157502 |
| 151 | MP0004233_abnormal_muscle_weight | 0.74547792 |
| 152 | MP0009115_abnormal_fat_cell | 0.73822510 |
| 153 | MP0000569_abnormal_digit_pigmentation | 0.73099039 |
| 154 | MP0001873_stomach_inflammation | 0.70237689 |
| 155 | MP0001663_abnormal_digestive_system | 0.64866050 |
| 156 | MP0001542_abnormal_bone_strength | 0.63816536 |
| 157 | MP0000703_abnormal_thymus_morphology | 0.62512637 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Muscle fiber splitting (HP:0003555) | 5.28709679 |
| 2 | Muscle fiber inclusion bodies (HP:0100299) | 5.26392009 |
| 3 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 5.26199028 |
| 4 | Recurrent bacterial skin infections (HP:0005406) | 5.04851166 |
| 5 | Stomatitis (HP:0010280) | 5.03961977 |
| 6 | Hyporeflexia of lower limbs (HP:0002600) | 5.03253236 |
| 7 | Sudden death (HP:0001699) | 5.00551371 |
| 8 | Calf muscle hypertrophy (HP:0008981) | 4.69510772 |
| 9 | Exercise-induced myalgia (HP:0003738) | 4.67608164 |
| 10 | Right ventricular cardiomyopathy (HP:0011663) | 4.64414523 |
| 11 | Recurrent abscess formation (HP:0002722) | 4.60110778 |
| 12 | Nemaline bodies (HP:0003798) | 4.47446522 |
| 13 | Muscle hypertrophy of the lower extremities (HP:0008968) | 4.47045574 |
| 14 | Abnormality of macrophages (HP:0004311) | 4.42719874 |
| 15 | Abnormality of the calf musculature (HP:0001430) | 4.35846699 |
| 16 | Exercise-induced muscle cramps (HP:0003710) | 4.35388795 |
| 17 | Type 1 muscle fiber predominance (HP:0003803) | 4.18988171 |
| 18 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.17975616 |
| 19 | Areflexia of lower limbs (HP:0002522) | 4.15135510 |
| 20 | Myositis (HP:0100614) | 4.13616880 |
| 21 | Ventricular tachycardia (HP:0004756) | 4.04301220 |
| 22 | Optic neuritis (HP:0100653) | 4.03567110 |
| 23 | Retrobulbar optic neuritis (HP:0100654) | 4.03567110 |
| 24 | Orchitis (HP:0100796) | 3.97411648 |
| 25 | Round ear (HP:0100830) | 3.96889800 |
| 26 | Increased connective tissue (HP:0009025) | 3.96537775 |
| 27 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.81763283 |
| 28 | Subaortic stenosis (HP:0001682) | 3.81763283 |
| 29 | EMG: myopathic abnormalities (HP:0003458) | 3.74485981 |
| 30 | Distal lower limb muscle weakness (HP:0009053) | 3.67970448 |
| 31 | Abnormality of glycolipid metabolism (HP:0010969) | 3.63175081 |
| 32 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.63175081 |
| 33 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.63175081 |
| 34 | Arterial tortuosity (HP:0005116) | 3.44810476 |
| 35 | Mediastinal lymphadenopathy (HP:0100721) | 3.35663648 |
| 36 | Amyloidosis (HP:0011034) | 3.35253460 |
| 37 | Spontaneous hematomas (HP:0007420) | 3.29748503 |
| 38 | Ulnar deviation of the wrist (HP:0003049) | 3.29233569 |
| 39 | Distal arthrogryposis (HP:0005684) | 3.29014136 |
| 40 | Malignant hyperthermia (HP:0002047) | 3.23713335 |
| 41 | Difficulty running (HP:0009046) | 3.22838700 |
| 42 | Difficulty climbing stairs (HP:0003551) | 3.20301257 |
| 43 | Recurrent skin infections (HP:0001581) | 3.14020100 |
| 44 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.10527993 |
| 45 | Vascular tortuosity (HP:0004948) | 3.07009581 |
| 46 | Distal lower limb amyotrophy (HP:0008944) | 3.04366254 |
| 47 | Keratoconjunctivitis sicca (HP:0001097) | 2.99917829 |
| 48 | Syncope (HP:0001279) | 2.99127190 |
| 49 | Atrial fibrillation (HP:0005110) | 2.97005752 |
| 50 | Eczematoid dermatitis (HP:0000976) | 2.92720471 |
| 51 | Meningitis (HP:0001287) | 2.91812322 |
| 52 | Increased cerebral lipofuscin (HP:0011813) | 2.91504714 |
| 53 | Systemic lupus erythematosus (HP:0002725) | 2.88299991 |
| 54 | Recurrent fungal infections (HP:0002841) | 2.82278458 |
| 55 | Asymmetric septal hypertrophy (HP:0001670) | 2.80234033 |
| 56 | Vasculitis (HP:0002633) | 2.80027898 |
| 57 | Aortic aneurysm (HP:0004942) | 2.78128421 |
| 58 | Primary atrial arrhythmia (HP:0001692) | 2.76976883 |
| 59 | Increased IgE level (HP:0003212) | 2.76735407 |
| 60 | Keratoconjunctivitis (HP:0001096) | 2.74763405 |
| 61 | Recurrent viral infections (HP:0004429) | 2.72743156 |
| 62 | Lipoatrophy (HP:0100578) | 2.72226071 |
| 63 | Disinhibition (HP:0000734) | 2.70341931 |
| 64 | Facial diplegia (HP:0001349) | 2.70186831 |
| 65 | T lymphocytopenia (HP:0005403) | 2.67683682 |
| 66 | Myopathic facies (HP:0002058) | 2.66779347 |
| 67 | Pustule (HP:0200039) | 2.65956044 |
| 68 | Lip pit (HP:0100267) | 2.59991001 |
| 69 | Episodic fever (HP:0001954) | 2.59403521 |
| 70 | Supraventricular tachycardia (HP:0004755) | 2.58969601 |
| 71 | Supraventricular arrhythmia (HP:0005115) | 2.54651033 |
| 72 | Abnormality of T cell number (HP:0011839) | 2.47725128 |
| 73 | Cerebral aneurysm (HP:0004944) | 2.46139587 |
| 74 | Hip contracture (HP:0003273) | 2.46095709 |
| 75 | Popliteal pterygium (HP:0009756) | 2.45561223 |
| 76 | Vacuolated lymphocytes (HP:0001922) | 2.44584718 |
| 77 | Dysostosis multiplex (HP:0000943) | 2.44444644 |
| 78 | Loss of speech (HP:0002371) | 2.43702399 |
| 79 | Ventricular arrhythmia (HP:0004308) | 2.40760456 |
| 80 | Fatigable weakness (HP:0003473) | 2.39932416 |
| 81 | Abnormality of the neuromuscular junction (HP:0003398) | 2.39932416 |
| 82 | Encephalitis (HP:0002383) | 2.39451192 |
| 83 | Hematochezia (HP:0002573) | 2.39107855 |
| 84 | Pulmonary infiltrates (HP:0002113) | 2.38850991 |
| 85 | Lower limb amyotrophy (HP:0007210) | 2.37538070 |
| 86 | Leukocytosis (HP:0001974) | 2.35642432 |
| 87 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.34789932 |
| 88 | Recurrent cutaneous fungal infections (HP:0011370) | 2.34789932 |
| 89 | Urethral obstruction (HP:0000796) | 2.32787486 |
| 90 | Osteomyelitis (HP:0002754) | 2.31903503 |
| 91 | Arterial thrombosis (HP:0004420) | 2.31896914 |
| 92 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.31656436 |
| 93 | Hemoptysis (HP:0002105) | 2.30921603 |
| 94 | Autoimmune thrombocytopenia (HP:0001973) | 2.30331690 |
| 95 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.29804943 |
| 96 | Palmoplantar keratoderma (HP:0000982) | 2.28976304 |
| 97 | Obstructive lung disease (HP:0006536) | 2.28907112 |
| 98 | Chronic obstructive pulmonary disease (HP:0006510) | 2.28907112 |
| 99 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.27637258 |
| 100 | Gastrointestinal infarctions (HP:0005244) | 2.27248798 |
| 101 | Gangrene (HP:0100758) | 2.25404035 |
| 102 | Urticaria (HP:0001025) | 2.25276089 |
| 103 | Panhypogammaglobulinemia (HP:0003139) | 2.25038282 |
| 104 | EMG: neuropathic changes (HP:0003445) | 2.24476172 |
| 105 | Increased serum ferritin (HP:0003281) | 2.22992141 |
| 106 | Abnormality of the ischium (HP:0003174) | 2.21537993 |
| 107 | Frequent falls (HP:0002359) | 2.20482998 |
| 108 | Hypoplastic ischia (HP:0003175) | 2.19970967 |
| 109 | Dilated cardiomyopathy (HP:0001644) | 2.19465948 |
| 110 | Gingivitis (HP:0000230) | 2.16990847 |
| 111 | Mutism (HP:0002300) | 2.16916101 |
| 112 | Neck muscle weakness (HP:0000467) | 2.15611622 |
| 113 | Bundle branch block (HP:0011710) | 2.14724292 |
| 114 | Polyneuropathy (HP:0001271) | 2.13872036 |
| 115 | Chest pain (HP:0100749) | 2.10875661 |
| 116 | Myocardial infarction (HP:0001658) | 2.08276810 |
| 117 | Cellulitis (HP:0100658) | 2.07934812 |
| 118 | Interstitial pulmonary disease (HP:0006530) | 2.07607365 |
| 119 | Palmoplantar hyperkeratosis (HP:0000972) | 2.06928577 |
| 120 | Scapular winging (HP:0003691) | 2.06405770 |
| 121 | Autoimmune hemolytic anemia (HP:0001890) | 2.04160300 |
| 122 | Myoglobinuria (HP:0002913) | 2.03891592 |
| 123 | Myotonia (HP:0002486) | 2.01608946 |
| 124 | Absent phalangeal crease (HP:0006109) | 2.01127528 |
| 125 | Sudden cardiac death (HP:0001645) | 2.00584903 |
| 126 | Abnormal atrioventricular conduction (HP:0005150) | 1.99059554 |
| 127 | Increased CSF protein (HP:0002922) | 1.99012041 |
| 128 | Aortic dissection (HP:0002647) | 1.98063272 |
| 129 | Vertigo (HP:0002321) | 1.96045412 |
| 130 | Limited hip movement (HP:0008800) | 1.94860714 |
| 131 | Achilles tendon contracture (HP:0001771) | 1.94681081 |
| 132 | Bicuspid aortic valve (HP:0001647) | 1.94439707 |
| 133 | Testicular atrophy (HP:0000029) | 1.94437265 |
| 134 | Restrictive lung disease (HP:0002091) | 1.94022268 |
| 135 | Increased variability in muscle fiber diameter (HP:0003557) | 1.93519956 |
| 136 | Fatigue (HP:0012378) | 1.92617258 |
| 137 | Abnormality of iron homeostasis (HP:0011031) | 1.92402398 |
| 138 | Atrioventricular block (HP:0001678) | 1.92073583 |
| 139 | Rhabdomyolysis (HP:0003201) | 1.91931764 |
| 140 | Palmar hyperkeratosis (HP:0010765) | 1.91049736 |
| 141 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.88476562 |
| 142 | Glomerulonephritis (HP:0000099) | 1.88421286 |
| 143 | Sepsis (HP:0100806) | 1.88062322 |
| 144 | Slow saccadic eye movements (HP:0000514) | 1.86587952 |
| 145 | Calcaneovalgus deformity (HP:0001848) | 1.86410310 |
| 146 | Thick nail (HP:0001805) | 1.86174483 |
| 147 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.85159377 |
| 148 | Gowers sign (HP:0003391) | 1.84677834 |
| 149 | Neuronal loss in central nervous system (HP:0002529) | 1.84454613 |
| 150 | Long clavicles (HP:0000890) | 1.83965013 |
| 151 | Abnormality of the endocardium (HP:0004306) | 1.83953454 |
| 152 | Colitis (HP:0002583) | 1.82337986 |
| 153 | Muscular dystrophy (HP:0003560) | 1.82269040 |
| 154 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.81915471 |
| 155 | Aneurysm (HP:0002617) | 1.80839084 |
| 156 | Ventricular fibrillation (HP:0001663) | 1.80805147 |
| 157 | Fetal akinesia sequence (HP:0001989) | 1.80636272 |
| 158 | Malnutrition (HP:0004395) | 1.80230491 |
| 159 | Osteolytic defects of the hand bones (HP:0009699) | 1.79709732 |
| 160 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.79709732 |
| 161 | Heart block (HP:0012722) | 1.79374979 |
| 162 | Agammaglobulinemia (HP:0004432) | 1.78726741 |
| 163 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.77051237 |
| 164 | Pulmonary embolism (HP:0002204) | 1.76694637 |
| 165 | Plantar hyperkeratosis (HP:0007556) | 1.76490384 |
| 166 | Alveolar cell carcinoma (HP:0006519) | 1.76336410 |
| 167 | Mitral valve prolapse (HP:0001634) | 1.76239514 |
| 168 | Bulbar palsy (HP:0001283) | 1.75043490 |
| 169 | Abnormality of the Achilles tendon (HP:0005109) | 1.74168379 |
| 170 | Skin pits (HP:0100276) | 1.73685169 |
| 171 | Spinal rigidity (HP:0003306) | 1.71383446 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TGFBR2 | 5.04372490 |
| 2 | OBSCN | 4.39945945 |
| 3 | IRAK3 | 3.09106505 |
| 4 | TTN | 2.92617232 |
| 5 | BLK | 2.76064394 |
| 6 | STK24 | 2.73320561 |
| 7 | PRPF4B | 2.68306595 |
| 8 | MAP3K3 | 2.63604739 |
| 9 | DMPK | 2.56756254 |
| 10 | RIPK4 | 2.49914405 |
| 11 | MAPK15 | 2.37519419 |
| 12 | IRAK4 | 2.32165277 |
| 13 | LATS1 | 2.11501866 |
| 14 | MAP3K13 | 2.06727085 |
| 15 | GRK7 | 2.03262276 |
| 16 | STK38L | 1.96030744 |
| 17 | STK10 | 1.91474300 |
| 18 | IKBKE | 1.89603352 |
| 19 | STK3 | 1.68330190 |
| 20 | MAPK12 | 1.63649681 |
| 21 | MUSK | 1.50937019 |
| 22 | IRAK1 | 1.49242933 |
| 23 | TAOK2 | 1.47477003 |
| 24 | MAPK7 | 1.46584552 |
| 25 | MAP2K3 | 1.45158020 |
| 26 | MAP3K7 | 1.45017566 |
| 27 | IRAK2 | 1.44917573 |
| 28 | MAPKAPK3 | 1.42749065 |
| 29 | CAMK1D | 1.39803414 |
| 30 | TAOK3 | 1.38048932 |
| 31 | ZAK | 1.37138751 |
| 32 | STK38 | 1.35393508 |
| 33 | PIK3CG | 1.34242411 |
| 34 | EPHA2 | 1.28867287 |
| 35 | MOS | 1.24914481 |
| 36 | MAP4K1 | 1.24192542 |
| 37 | FGFR4 | 1.23727719 |
| 38 | ITK | 1.23295312 |
| 39 | FGFR3 | 1.18461654 |
| 40 | CHUK | 1.17508920 |
| 41 | NEK9 | 1.17287009 |
| 42 | BTK | 1.15734028 |
| 43 | MST4 | 1.12834870 |
| 44 | SIK3 | 1.11491294 |
| 45 | FGR | 1.09459037 |
| 46 | TRPM7 | 1.08782916 |
| 47 | RIPK1 | 1.07552904 |
| 48 | JAK2 | 1.04800239 |
| 49 | FES | 1.04356552 |
| 50 | TNK2 | 1.04054550 |
| 51 | CDK6 | 1.03403674 |
| 52 | PHKG2 | 1.02689941 |
| 53 | PHKG1 | 1.02689941 |
| 54 | MATK | 1.01916450 |
| 55 | MAP3K6 | 1.00251958 |
| 56 | CDK12 | 0.97737659 |
| 57 | CAMK1G | 0.97533396 |
| 58 | JAK1 | 0.97393356 |
| 59 | MAP2K4 | 0.96684238 |
| 60 | MAP3K2 | 0.91905203 |
| 61 | MAP3K10 | 0.89809931 |
| 62 | NLK | 0.89584579 |
| 63 | RPS6KB2 | 0.88512877 |
| 64 | LATS2 | 0.87446052 |
| 65 | MAP3K5 | 0.87352468 |
| 66 | TIE1 | 0.85223664 |
| 67 | LYN | 0.84841493 |
| 68 | PINK1 | 0.84815838 |
| 69 | CSF1R | 0.81461770 |
| 70 | MST1R | 0.81445861 |
| 71 | MELK | 0.81183316 |
| 72 | LCK | 0.79409691 |
| 73 | PDK1 | 0.78863372 |
| 74 | TYK2 | 0.78451067 |
| 75 | PDK2 | 0.77284574 |
| 76 | IKBKB | 0.76234874 |
| 77 | KIT | 0.74653885 |
| 78 | PAK3 | 0.72733689 |
| 79 | CDC42BPA | 0.71932711 |
| 80 | RPS6KA4 | 0.71759097 |
| 81 | HCK | 0.70876213 |
| 82 | PDPK1 | 0.70860702 |
| 83 | TRIB3 | 0.70683765 |
| 84 | CDK3 | 0.69712584 |
| 85 | CSK | 0.69586273 |
| 86 | PDK3 | 0.68852884 |
| 87 | PDK4 | 0.68852884 |
| 88 | EPHB1 | 0.68524549 |
| 89 | BMPR2 | 0.67590623 |
| 90 | MAPK4 | 0.67346350 |
| 91 | RPS6KL1 | 0.65547958 |
| 92 | RPS6KC1 | 0.65547958 |
| 93 | PRKD1 | 0.62740597 |
| 94 | TXK | 0.62711266 |
| 95 | KSR2 | 0.61900487 |
| 96 | MARK2 | 0.60352626 |
| 97 | ALK | 0.59827341 |
| 98 | ZAP70 | 0.58838448 |
| 99 | ILK | 0.58508599 |
| 100 | CAMKK2 | 0.57418173 |
| 101 | MAP3K14 | 0.56494189 |
| 102 | PIM2 | 0.56145508 |
| 103 | MAPKAPK2 | 0.56061992 |
| 104 | SGK3 | 0.55831313 |
| 105 | YES1 | 0.55763667 |
| 106 | MAP3K9 | 0.55411553 |
| 107 | MARK3 | 0.54921705 |
| 108 | PLK2 | 0.53790309 |
| 109 | RPS6KA6 | 0.53722151 |
| 110 | GRK6 | 0.53584588 |
| 111 | PRKAA2 | 0.53329629 |
| 112 | MAPK11 | 0.52478953 |
| 113 | MAP2K1 | 0.51822925 |
| 114 | ABL1 | 0.50821775 |
| 115 | PKN2 | 0.50563184 |
| 116 | TAOK1 | 0.49767142 |
| 117 | SIK1 | 0.49384464 |
| 118 | JAK3 | 0.49282041 |
| 119 | DDR2 | 0.48906391 |
| 120 | MAP3K11 | 0.48179209 |
| 121 | RPS6KA1 | 0.47947088 |
| 122 | EPHA3 | 0.47651074 |
| 123 | SGK2 | 0.47527906 |
| 124 | RAF1 | 0.47329226 |
| 125 | LRRK2 | 0.47144652 |
| 126 | ERN1 | 0.46764670 |
| 127 | PIM1 | 0.45947644 |
| 128 | PDGFRB | 0.44982400 |
| 129 | SYK | 0.43859459 |
| 130 | FER | 0.43694984 |
| 131 | TYRO3 | 0.42732319 |
| 132 | CAMK4 | 0.42709781 |
| 133 | MAP3K1 | 0.40623144 |
| 134 | PIK3CA | 0.39229697 |
| 135 | HIPK2 | 0.39197042 |
| 136 | MAP2K2 | 0.39181987 |
| 137 | TEC | 0.39054094 |
| 138 | TBK1 | 0.38963154 |
| 139 | CDK4 | 0.37416407 |
| 140 | RPS6KA2 | 0.34356447 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.65121267 |
| 2 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.50991196 |
| 3 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.45438964 |
| 4 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.28535463 |
| 5 | Legionellosis_Homo sapiens_hsa05134 | 2.14708648 |
| 6 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.02840463 |
| 7 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.00583251 |
| 8 | Adherens junction_Homo sapiens_hsa04520 | 1.97804079 |
| 9 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.94161124 |
| 10 | Malaria_Homo sapiens_hsa05144 | 1.86962480 |
| 11 | Allograft rejection_Homo sapiens_hsa05330 | 1.84465219 |
| 12 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.84271135 |
| 13 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.84040458 |
| 14 | Other glycan degradation_Homo sapiens_hsa00511 | 1.73385643 |
| 15 | Leishmaniasis_Homo sapiens_hsa05140 | 1.69011022 |
| 16 | Viral myocarditis_Homo sapiens_hsa05416 | 1.68360755 |
| 17 | Asthma_Homo sapiens_hsa05310 | 1.54803719 |
| 18 | Circadian rhythm_Homo sapiens_hsa04710 | 1.54315462 |
| 19 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.53530906 |
| 20 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.52138511 |
| 21 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.50890355 |
| 22 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.50544153 |
| 23 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.50199127 |
| 24 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.48914214 |
| 25 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.47140628 |
| 26 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.42703695 |
| 27 | Pertussis_Homo sapiens_hsa05133 | 1.39401034 |
| 28 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.32588068 |
| 29 | Insulin resistance_Homo sapiens_hsa04931 | 1.30513531 |
| 30 | Platelet activation_Homo sapiens_hsa04611 | 1.23561089 |
| 31 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.23308207 |
| 32 | Lysosome_Homo sapiens_hsa04142 | 1.22249952 |
| 33 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.21979167 |
| 34 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.19893760 |
| 35 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.19638626 |
| 36 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.19236554 |
| 37 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.19202284 |
| 38 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.16885849 |
| 39 | Focal adhesion_Homo sapiens_hsa04510 | 1.16731895 |
| 40 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.16666499 |
| 41 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.14847731 |
| 42 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.13766232 |
| 43 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.13760232 |
| 44 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.12409132 |
| 45 | MAPK signaling pathway_Homo sapiens_hsa04010 | 1.11881342 |
| 46 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.09487022 |
| 47 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.08509995 |
| 48 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.08282237 |
| 49 | Tuberculosis_Homo sapiens_hsa05152 | 1.06332105 |
| 50 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.04952888 |
| 51 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.04237350 |
| 52 | Tight junction_Homo sapiens_hsa04530 | 1.03585361 |
| 53 | Colorectal cancer_Homo sapiens_hsa05210 | 1.03161243 |
| 54 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.02327734 |
| 55 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.02306195 |
| 56 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.02272844 |
| 57 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.01616724 |
| 58 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.00587486 |
| 59 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.99686410 |
| 60 | Hepatitis B_Homo sapiens_hsa05161 | 0.98835783 |
| 61 | Phagosome_Homo sapiens_hsa04145 | 0.97862263 |
| 62 | Renin secretion_Homo sapiens_hsa04924 | 0.97452674 |
| 63 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.97391835 |
| 64 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.96976757 |
| 65 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.96042105 |
| 66 | Hepatitis C_Homo sapiens_hsa05160 | 0.95914343 |
| 67 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.94931673 |
| 68 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.93768134 |
| 69 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.91426573 |
| 70 | Salmonella infection_Homo sapiens_hsa05132 | 0.89389794 |
| 71 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.89167403 |
| 72 | Influenza A_Homo sapiens_hsa05164 | 0.87206615 |
| 73 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.86752176 |
| 74 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.86589205 |
| 75 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.85594723 |
| 76 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.85030920 |
| 77 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.83261026 |
| 78 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.83186466 |
| 79 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.83048192 |
| 80 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.81212445 |
| 81 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.80498910 |
| 82 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.79519435 |
| 83 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.79495063 |
| 84 | Long-term potentiation_Homo sapiens_hsa04720 | 0.77723441 |
| 85 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.77285570 |
| 86 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.77102099 |
| 87 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.76685349 |
| 88 | Measles_Homo sapiens_hsa05162 | 0.75787061 |
| 89 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.75732524 |
| 90 | Glioma_Homo sapiens_hsa05214 | 0.73699053 |
| 91 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.73611613 |
| 92 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.72338003 |
| 93 | HTLV-I infection_Homo sapiens_hsa05166 | 0.71295616 |
| 94 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.70823586 |
| 95 | Amoebiasis_Homo sapiens_hsa05146 | 0.70267133 |
| 96 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.69689068 |
| 97 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.67292539 |
| 98 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.67178887 |
| 99 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.66578760 |
| 100 | Apoptosis_Homo sapiens_hsa04210 | 0.66296871 |
| 101 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.65466695 |
| 102 | Shigellosis_Homo sapiens_hsa05131 | 0.65035592 |
| 103 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.64326978 |
| 104 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.64201127 |
| 105 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.63666483 |
| 106 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.62258167 |
| 107 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.61700272 |
| 108 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.61092239 |
| 109 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.61062426 |
| 110 | Olfactory transduction_Homo sapiens_hsa04740 | 0.59808486 |
| 111 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.59588583 |
| 112 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.58904614 |
| 113 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.58599280 |
| 114 | Bladder cancer_Homo sapiens_hsa05219 | 0.57468069 |
| 115 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.57456281 |
| 116 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.56572355 |
| 117 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.55766584 |
| 118 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.55394794 |
| 119 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.54414696 |
| 120 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.53831920 |
| 121 | Prion diseases_Homo sapiens_hsa05020 | 0.53559082 |
| 122 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.53017987 |
| 123 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.52765889 |
| 124 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.52485220 |
| 125 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.52394181 |
| 126 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.51538646 |
| 127 | Prostate cancer_Homo sapiens_hsa05215 | 0.46603727 |
| 128 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.46468821 |
| 129 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.45062121 |
| 130 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.43431026 |
| 131 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.39637877 |

